HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Poop pills may reboot liver cancer therapy
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can help liver cancer patients who stopped responding to standard drugs. Fifteen adults with advanced liver cancer will receive FMT along with atezolizumab and bevacizumab to see if the combination can restore tumor con…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jun 23, 2026 23:34 UTC
-
New drug cocktail shows promise for advanced liver cancer
Disease control Recruiting nowThis study tests whether adding chemotherapy to a two-drug combination (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will participate. The g…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
Liver cancer trial adds a resistance-blocker to standard chemo – could it boost success?
Disease control Recruiting nowThis study tests whether adding nicardipine (a drug that blocks a cancer resistance protein) to standard chemoembolization (TACE) improves outcomes for people with liver cancer. About 152 adults with untreated liver tumors will be randomly assigned to receive either the standard …
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 22, 2026 12:01 UTC
-
New hope for liver cancer patients: smart trial aims to match treatments to individuals
Disease control Recruiting nowThis study tests several new drug combinations for people with advanced liver cancer whose first treatment stopped working. It involves 350 adults and uses advanced imaging and genetic tests to find which treatment works best for each person. The goal is to shrink or control the …
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC
-
New drug shows promise for tough liver cancer cases
Disease control Recruiting nowThis study tests a drug called Becotatug vedotin in 40 adults with advanced liver cancer that has worsened after standard treatments. The goal is to see if it can shrink tumors and help control the disease. Participants receive the drug and are monitored for safety and response.
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New blood test could sniff out liver cancer before It's too late
Diagnosis Recruiting nowThis study is testing a new blood test called Delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare results from 200 people—half with liver cancer and half with cirrhosis but no cancer—to measure how sensitive and specific …
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Sponsor: Epiliquid Holding, Inc • Aim: Diagnosis
Last updated Jun 08, 2026 13:04 UTC
-
Could liver cancer patients skip the hospital stay? new trial tests outpatient care
Symptom relief Recruiting nowThis study tests whether people with liver cancer can receive a treatment that goes through an artery (like chemo or radiation beads) as an outpatient instead of staying in the hospital. About 206 adults with liver cancer will be randomly assigned to either outpatient or standard…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 17, 2026 12:02 UTC
-
Simple gel may prevent painful side effect of liver cancer drug
Symptom relief Recruiting nowThis study tests if applying a topical gel (indomethacin) to the hands before starting sorafenib can prevent or reduce hand-foot skin reactions, a common and painful side effect. About 39 adults with advanced liver cancer will use the gel twice daily for up to 12 weeks. The goal …
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 01, 2026 18:04 UTC